Research

Items by Fotaki, Nikoletta

Up a level
Export as [feed] RSS 1.0 [feed] Atom [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 56.

Book Sections

Fotaki, N., Long, C. M., Tang, K. and Chokshi, H., 2014. Dissolution of amorphous solid dispersions : theory and practice. In: Shah, N. H., Sandhu, H. K., Choi, D. S., Chokshi, H. K. and Malick, W., eds. Amorphous Solid Dispersions. New York, U. S. A.: Springer US.

Edginton, A. M. and Fotaki, N., 2010. Oral drug absorption in pediatric populations. In: Dressman, J. B. and Reppas, C., eds. Oral Drug Absorption: Prediction and Assessment, 2nd Edition. Vol. 193. New York: Informa Healthcare, pp. 108-126. (Drugs and the Pharmaceutical Sciences)

Articles

Batchelor, H.K., Fotaki, N. and Klein, S., 2014. Paediatric oral biopharmaceutics : Key considerations and current challenges. Advanced Drug Delivery Reviews, 73, pp. 102-126.

Khroyan, T. V., Wu, J., Polgar, W. E., Cami-Kobeci, G., Fotaki, N., Husbands, S. M. and Toll, L., 2014. Forthcoming. BU08073 a buprenorphine analog with partial agonist activity at mu receptors in vitro but long-lasting opioid antagonist activity in vivo in mice. British Journal of Pharmacology

Fotaki, N. and Klein, S., 2013. Mechanistic understanding of the effect of PPIs and acidic carbonated beverages on the oral absorption of itraconazole based on absorption modeling with appropriate in vitro data. Molecular Pharmaceutics, 10 (11), pp. 4016-4023.

Tomaszewska, I., Karki, S., Shur, J., Price, R. and Fotaki, N., 2013. Pharmaceutical characterisation and evaluation of cocrystals : importance of in vitro dissolution conditions and type of coformer. International Journal of Pharmaceutics, 453 (2), pp. 380-388.

Fotaki, N., Brown, W., Kochling, J., Chokshi, H., Miao, H., Tang, K. and Gray, V., 2013. Rationale for selection of dissolution media: three case studies. Dissolution Technologies, 20 (3), pp. 6-13.

Fotaki, N., Martin, G.P. and Krämer, J., 2013. Dissolution highlights from the 2012 AAPS annual meeting in Chicago. Dissolution Technologies, 20 (2), pp. 57-59.

Fotaki, N., Gray, V., Kesisoglou, F., Mayock, S., Mirza, T. and Salt, A., 2013. Survey results for in vitro-in vivo correlations (IVIVC) : Critical variables for success. Dissolution Technologies, 20 (2), pp. 48-50.

Fotaki, N., Karki, S., Price, R., Chapman, A. and Lenke, J., 2013. Forthcoming. Surface dissolution UV imaging for studying properties of pharmaceutical cocrystals for oral administration. AAPS Journal

Bittner, B., McIntyre, C., Tian, H., Tang, K., Shah, N., Phuapradit, W., Ahmed, H., Chokshi, H., Infeld, M., Fotaki, N., Ma, H., Portron, A., Jordan, P. and Schmidt, J., 2012. Phase I clinical study to select a novel oral formulation for ibandronate containing the excipient sodium N-[8-(2-hydroxybenzoyl) amino] caprylate (SNAC). Die Pharmazie - An International Journal of Pharmaceutical Sciences, 67 (3), pp. 233-241.

Gray, V., Fotaki, N. and Martin, G. P., 2012. Dissolution highlights from the 2011 AAPS annual meeting in Washington, D. C. Dissolution Technologies, 19 (1), pp. 69-70.

Long, C., Tang, K., Chokshi, H. and Fotaki, N., 2012. Forthcoming. Development of PBPK model for an amorphous oral formulation of a poorly soluble drug : Importance of in vitro solubility and dissolution data. AAPS Journal

Tomaszewska, I., Price, R. and Fotaki, N., 2012. Forthcoming. Investigation of the mechanism of dissolution from pharmaceutical cocrystals and implications for oral administration. AAPS Journal

Box, K., Comer, J., Mole, J., Taylor, R., Karki, S., Price, R. and Fotaki, N., 2012. Forthcoming. Small scale assays for studying dissolution and precipitation of pharmaceutical cocrystals. AAPS Journal

Fotaki, N., 2011. Flow-through cell apparatus (USP apparatus 4) : Operation and features. Dissolution Technologies, 18 (4), pp. 46-49.

Martin, G. P., Fotaki, N., Salt, A. D. and Gray, V. A., 2011. 2010 Pharmaceutical Sciences World Congress Provides Dissolution Programming with an International Flavor. Dissolution Technologies, 18 (2), pp. 38-42.

Long, C., Tang, K., Chokshi, H. and Fotaki, N., 2011. Dissolution testing for amorphous formulations : Effect of media and hydrodynamics. AAPS Journal, 13 (S2).

Tomaszewska, I., Price, R. and Fotaki, N., 2011. Pharmaceutical cocrystals : Effect of media and coformer on dissolution. AAPS Journal, 13 (S2).

Pergament, V., Schatton, W. and Fotaki, N., 2011. Study of release properties from marine sponge collagen coated formulations. AAPS Journal, 13 (S2).

Fotaki, N. and Vertzoni, M., 2010. Biorelevant dissolution methods and their applications in in vitroin vivo correlations for oralformulations. The Open Drug Delivery Journal, 4 (1), pp. 2-13.

Fotaki, N., 2010. Controlled release formulations of BSC class I compounds. AAPS Journal, 12 (S2).

Fotaki, N., Aivaliotis, A., Butler, J., Dressman, J., Fischbach, M., Hempenstall, J., Klein, S. and Reppas, C., 2009. A comparative study of different release apparatus in generating in vitro–in vivo correlations for extended release formulations. European Journal of Pharmaceutics and Biopharmaceutics, 73 (1), pp. 115-120.

Wang, Q. X., Fotaki, N. and Mao, Y., 2009. Biorelevant dissolution: Methodology and application in drug development. Dissolution Technologies, 16 (3), pp. 6-12.

Fotaki, N., 2009. Pros and cons of methods used for the prediction of oral drug absorption. Expert Review of Clinical Pharmacology, 2 (2), pp. 195-208.

Fotaki, N., Obwoge, E. and Tang, K., 2007. Development of an in vitro-in vivo correlation (IVIVC) for a BCS Class II compound with pH-dependent solubility. AAPS Journal, 9 (S2).

Fotaki, N., Walwyn, C., Tang, K. and Chokshi, H., 2007. Flow through cell dissolution testing as a formulation screening and quality tool for the assessment of bioavailability. AAPS Journal, 9 (S2).

Dokoumetzidis, A., Kalantzi, L. and Fotaki, N., 2007. Predictive models for oral drug absorption: from in silico methods to integrated dynamical models. Expert Opinion Drug Metabolism and Toxicology, 3 (4), pp. 491-505.

Rausl, D., Fotaki, N., Zanoski, R., Vertzoni, M., Cetina-Cizmek, B., Khan, M. Z. I. and Reppas, C., 2006. Intestinal permeability and excretion into bile control the arrival of amlodipine into the systemic circulation after oral administration. Journal of Pharmacy and Pharmacology, 58 (6), pp. 827-836.

Fotaki, N., Symillides, M. and Reppas, C., 2005. Canine vs. in vitro data for predicting input profiles of L-sulpiride after oral administration. European Journal of Pharmaceutical Sciences, 26 (3-4), pp. 324-333.

Fotaki, N., Symillides, M. and Reppas, C., 2005. In vitro vs. canine date for predicting input profiles of isosorbide-5 mononitrate from oral extended release products on a confidence interval basis. European Journal of Pharmaceutical Sciences, 24, pp. 115-122.

Fotaki, N. and Reppas, C., 2005. The flow through cell methodology in the evaluation of intralumenal drug release characteristics. Dissolution Technologies, 12 (2), pp. 17-21.

Fotaki, N., Gikas, E., Halabalaki, M. and Reppas, C., 2004. An improved GC-MS method for the quantification of isosorbide-5-mononitrate in plasma. European Journal of Pharmaceutical Sciences, 23 (Supplement), S39.

Vertzoni, M., Fotaki, N., Kostewicz, E., Stippler, E., Leuner, C., Nicolaides, E., Dressman, J. and Reppas, C., 2004. Dissolution media simulating the intralumenal composition of the small intestine: physiological issues and practical aspects. Journal of Pharmacy and Pharmacology, 56 (4), pp. 453-462.

Fotaki, N. and Reppas, C., 2002. In vitro release vs canine data for predicting the absorption profile of levosulpiride in the Fed State. AAPS Journal, 4 (S1).

Fotaki, N. and Reppas, C., 2001. Protein digestion effects the release process in media simulating the composition of meals administered in bioequivalence studies. AAPS Journal, 3 (S1).

Loi, V., Fotaki, N., Reppas, C. and Wheatley, T., 2001. Release of phenylpropanolamine HCI from ethylcellulose-coated pellets in biorelevant media. Pharmaceutical Technology, 25 (3), pp. 44-50.

Fotaki, N., Vertzoni, M., Dressman, J. B. and Reppas, C., 2000. Optimising the in vitro conditions to simulate the release process in stomach after meals. European Journal of Pharmaceutical Scientists, 11 (S1), S44.

Conference or Workshop Items

Fotaki, N., Long, C. M., Cuppok-Rosiaux, Y., Marchaud, D., Garbacz, G., Lange, S. and Klein, S., 2014. Estimating in vivo drug release from a new theophylline Compritol® 888 ATO matrix formulation using appropriate biorelevant test methods. In: 41st Annual Meeting & Exposition of the Controlled Release Society (CRS), 2014, 2014-07-13 - 2014-07-16, Chicago.

Fotaki, N. and Brassine, C., 2013. Age related biorelevant dissolution testing for pediatric pellet formulations. In: 2013 AAPS Annual Meeting and Exposition, 2013-11-10 - 2013-11-14, San Antonio.

Pergament, V., Schatton, W., Guldutuna, S. and Fotaki, N., 2013. Development of marine sponge collagen coated lecithin formulations for the treatment of inflammatory bowel disease. In: PharmSci, 2013, 2013-09-02 - 2013-09-04, Edinburgh.

Fotaki, N., Box, K., Comer, J., Mole, J., Taylor, R., Karki, S. and Price, R., 2013. Dissolution and precipitation studies of carbamazepine cocrystals with small scale assays. In: 2013 AAPS Annual Meeting and Exposition, 2013-11-10 - 2013-11-14, San Antonio.

Fotaki, N., Long, C., Tang, K. and Chokshi, H., 2013. Surface dissolution UV imaging for studying properties of a poorly soluble weak basic compound. In: 2013 AAPS Annual Meeting and Exposition, 2013-11-10 - 2013-11-14, San Antonio.

Long, C. M., Tang, K., Chokski, H. and Fotaki, N., 2012. Investigation on the physiological relevant amount of surfactant in simulated gastric fluids for in vitro solubility and dissolution studies. In: PharmaTech 2012, 2012-11-20 - 2012-11-21, Kuala Lumpur.

Cabana Montenegro, S., Delgado-Charro, M. B. and Fotaki, N., 2012. Development and evaluation of age appropriate pellet formulations for an antiepileptic drug. In: 4th Conference of the European Paediatric Formulation Initiative (EuPFI) 2012, 2012-09-19 - 2012-09-20, Prague.

Tomaszewska, I. and Fotaki, N., 2012. Development of a PBPK model for a poorly soluble drug : importance of in vitro solubility and dissolution data. In: UK-PharmSci Meeting, 2012, 2012-09-12 - 2012-09-14, Nottingham.

Long, C., Tang, K., Chokshi, H. and Fotaki, N., 2012. In vitro dissolution characterization of an amorphous formulation of a BCS class II compound. In: UK-PharmSci Meeting, 2012, 2012-09-12 - 2012-09-14, Nottingham.

Long, C., Tang, K., Chokshi, H. and Fotaki, N., 2012. In vitro-in vivo correlations for an amorphous formulation of a poorly soluble compound. In: FIP Conference, 2012-10-03 - 2012-10-08, Amsterdam.

Tomaszewska, I., Price, R. and Fotaki, N., 2011. Development for pharmaceutical cocrystals. In: PharmSci APSGB Meeting, 2011-01-26, Nottingham.

Fotaki, N., Warren, K., Irish, N. and Haden Tebb, A., 2009. Development of in vitro-in vivo correlations (IVIVCs) for controlled release formulations of BSC Class I compounds. In: 2nd PharmSciFair, 2009-06-08 - 2009-06-12, Nice.

Fotaki, N., Obwoge, E., Tang, K. and Chokshi, H., 2007. Development of an in vitro-in vivo correlation (IVIVC) for a BCS Class II compound with pH-dependent solubility. In: American Association of Pharmaceutical Scientists (ΑΑPS) Annual Meeting and Exposition, 2007-11-09 - 2007-11-15, San Diego.

Fotaki, N., Walwyn, C., Tang, K. and Chokshi, H., 2007. Flow through cell dissolution testing as a formulation screening and quality tool for the assessment of bioavailability. In: American Association of Pharmaceutical Scientists (ΑΑPS) Annual Meeting and Exposition, 2007-11-09 - 2007-11-15, San Diego.

Fotaki, N., Aivaliotis, A. and Reppas, C., 2005. The USP IV apparatus for the assessment of intraluminal drug release profile from extended relase products in the fasted state. In: 2nd International Symposium on Scientific and Regulatory Aspects of Dissolution and Bioequivalence, 2005, 2005-01-01, Athens.

Fotaki, N. and Reppas, C., 2002. Biorelevant release data vs canine data for the prediction of isosorbide-5-mononitrate absorption profile from extended release products in the fasted state. In: SOCRATES Intensive Programme of Innovative Therapeutics : from Molecules to Drugs, 2002, 2002-06-02 - 2002-06-11, Crotone.

Vertzoni, M., Fotaki, N. and Reppas, C., 2000. Optimizing the in vitro dissolution test conditions to simulate the fed gastrointestinal tract. In: 6th European Intensive Course on New Forms and Routes for Administration of Drugs, 2000-01-01, Santiago de Compostela.

Loi, V., Fotaki, N., Reppas, C., Wheatley, T. and Dressman, J., 2000. Release of phenylpropanolamine pellets in media simulating the gastrointestinal tract. In: 3rd Panhellenic Congress of Clinical Chemistry, 2000, 2000-01-01, Athens.

This list was generated on Mon Sep 1 01:21:29 2014 IST.